Expanded Access Programs (EAPs) are no longer just an afterthought - they’re a strategic lever for access, evidence generation, and meaningful patient impact. From supply chain logistics to ethical frameworks and real-world data integration, this summit puts the operational side of EAPs front and center.

What is Covered?
- Practical frameworks for building scalable, ethical, and sustainable EAPs (in both emerging markets and high-income countries)
- How to bring real-world data, AI, forecasting, and supply chain resilience into your access strategy
- Case studies spanning rare diseases, gene therapies, commercial transitions, and multi-country rollouts
Access your free copy and start operationalizing your EAP strategy with clarity and confidence.

About Hanson Wade Group - 6th Operationalize Expanded Access Programs Summit East
Navigate Global Regulatory, Operational & Supply Complexities to Accelerate Patient Access, Harness Ethical Real-World Data, & Deliver Scalable Expanded Access Programs
EAPs are evolving rapidly, moving from reactive programs to strategic, patient-centered initiatives that shape global access. Organizations are navigating unprecedented complexity: collecting meaningful real-world data without overburdening sites, managing multi-country supply chains, integrating AI and digital tools to forecast demand and streamline operations, and meeting stringent regulatory and ethical requirements. At the same time, emerging markets and LMICs are becoming critical frontiers, requiring scalable, compliant solutions to ensure timely patient access. This evolving landscape demands actionable strategies, cross-functional collaboration, and innovative approaches to deliver care efficiently, ethically, and at scale.
The 6th Operationalize: Expanded Access Programs Summit brings together 140+ experts leading global EAP strategy and operations to share the tools, partnerships, and processes transforming access delivery today.
Download the Event Guide
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.